Selank (10mg)
Calming nootropic — vial, cartridge or nasal spray
630.000 ₫
A synthetic analog of the human peptide tuftsin, researched as one of the cleanest anxiolytic nootropics available — anxiety reduction without sedation, dependence or cognitive blunting. Russian clinical work shows modulation of GABA, serotonin and BDNF, with effects on mood, focus under stress and immune balance. Most users notice a calm-but-clear state within days, making it a strong daily tool for high-stress periods, exam prep or post-burnout recovery. Selank is widely run as a 14-day cycle, repeated as needed. Available as a 10mg vial (cartridge optional) or as 20mg and 40mg pre-mixed 10mL nasal sprays — those sizes are spray only. All formats deliver the same compound; spray is the most convenient daily option.
Dosage
Start 1 spray per nostril (~200 µg) once daily; after 1 week double to 2 sprays per nostril (research range 200–600 µg/day)
Duration of effect
Effects felt for 6-24 hours per dose (plasma half-life: Plasma ~5-10 min · Brain effects 6-24h)
See full half-life table →Key Features
- Reduces anxiety naturally
- Enhances cognitive function
- Improves stress resilience
- Nasal spray — no injection
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Can be administered nasally or subcutaneously. Daily or cyclical dosing. Best taken in the morning for optimal cognitive effects. Note: you will need 3x more of this product to achieve the same results nasally compared to subcutaneously.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Behavioural Neurology
Clinical Research
Selank demonstrated significant anxiolytic effects comparable to benzodiazepines but without sedation or cognitive impairment.
Read full studyAdditional Research
Source: Zozulia et al., Korsakov J Neurology & Psychiatry (2008)
In a comparative human trial of 62 patients with generalized anxiety disorder and neurasthenia, Selank produced anxiolytic effects comparable to medazepam without sedation, dependence, or cognitive impairment.
Read full study